We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
John Bean (JBT) Earnings and Revenues Surpass Estimates in Q4
Read MoreHide Full Article
John Bean Technologies Corporation (JBT - Free Report) reported adjusted earnings of $1.02 per share in fourth-quarter 2020, surpassing the Zacks Consensus Estimate of 89 cents by a margin of 15%. However, the bottom line declined 32% from the prior-year quarter reflecting the impact of the COVID-19 pandemic as reductions in global passenger air travel and global foodservice production impacted demand for the company’s products and services.
On a reported basis, the company’s earnings per share was 94 cents compared with the prior-year quarter’s $1.31.
Revenues of $439 million beat the Zacks Consensus Estimate of $428 million. Further, the top line slumped 20% from the prior-year quarter figure of $545 million.
John Bean Technologies Corporation Price, Consensus and EPS Surprise
In the reported quarter, the company’s total orders went up 2% to $492 million from the prior-year quarter. Orders in the JBT FoodTech segment dipped 2% year over year to $364 million. In the JBT AeroTech segment, orders improved 14% to $128 million from the prior-year quarter.
Backlog in the FoodTech segment increased 6% from the year-ago quarter to $427 million as of fourth-quarter 2020 end. The AeroTech segment’s backlog was $287 million at the end of the reported quarter, down 6% from the prior-year quarter. Total backlog of $713 million as of the end of the fourth quarter was up 1% year over year.
Cost and Margins
Cost of sales decreased 19% year over year to $306 million in the fourth quarter. Gross profit slumped 21% year over year to $133 million. Gross margin came in at 30.3% compared with the year-earlier quarter’s 30.8%.
Selling, general and administrative expenses were down 14% year over year to $89 million. Adjusted operating profit declined 32% year over year to $47 million. Adjusted operating margin was 10.7%, down 200 basis points from 12.7% in the prior-year quarter. In the reported quarter, adjusted EBITDA was around $660 million, reflecting a year-over-year plunge of 25%. Adjusted EBITDA margin was 15%, down from 16% in the year-ago quarter.
Segment Performance
JBT FoodTech: Net sales fell 10% year over year to $321 million as increase in recurring revenues was offset by decline in equipment demand. Adjusted operating profit amounted to $43.6 million, reflecting a decline of 18% from the prior-year quarter.
JBT AeroTech: Net sales were $118 million, reflecting a decline of 37% from the prior-year quarter. The segment’s adjusted operating profit plunged 56% year over year to $12.7 million.
Financial Performance
John Bean reported cash and cash equivalents of around $47.5 million at the end of 2020, up from $39.5 million at the end of fiscal 2019. The company generated around $252 million of cash from operating activities during 2020 compared with $111 million in the prior year. At the end of 2020, long-term debt was $522 million, down from $698 million as of end of 2019.
2020 Results
John Bean’s adjusted earnings per share in 2020 was $3.94, down 21% from the prior-year’s figure of $4.96. However, the bottom line beat the Zacks Consensus Estimate of $3.83. Including one-time items, the company delivered an earnings per share of $3.39 in 2020 compared with $4.03 in 2019. Sales declined 11% year over year to $1,729 million from the prior-year figure of $1,946 million. The top line surpassed the Zacks Consensus Estimate of $1,720 million.
Guidance
John Bean expects the seasonally slower first-quarter 2021 revenues to be $400-$425 million. While the FoodTech segments revenues for the ongoing quarter are projected between $300 million and $315 million, the same for the AeroTech segment are anticipated in the range of $100 million to $110 million.
The FoodTech segment’s operating margins are expected in the band of 13% to 13.5% and adjusted EBITDA margins to be 18.25-18.75%. For AeroTech, operating margins are forecasted to be 7.0-7.5%, while adjusted EBITDA margins are expected between 8.0% and 8.5%. Earnings per share for first-quarter 2021 is expected to range between 70 cents to 80 cents.
For 2021, John Bean anticipates an increase of 5-8% in revenues for the FoodTech segment. Operating margins are expected between 14% and 15%, and adjusted EBITDA margins in the band of 19.5% to 20%.
The AeroTech segment’s revenue growth is expected to be flat to 5% in 2021. Operating margins are anticipated between 10.75% and 11.25%, and adjusted EBITDA margins in the range of 12.0% to 12.5%.
The company projects adjusted earnings per share to be $4.30-$4.55 for 2021. The mid-point of the guidance range suggests growth of 12% from earnings of $3.94 per share in 2020.
Price Performance
John Bean’s shares have gained 25% in the past year compared with the industry’s rally of 73.9%.
Zacks Rank & Stocks to Consider
John Bean carries a Zacks Rank #4 (Sell).
Some better-ranked stocks in the Industrial Products sector include Myers Industries, Inc. (MYE - Free Report) , AGCO Corporation (AGCO - Free Report) and Avery Dennison Corporation (AVY - Free Report) . While Myers Industries sports a Zacks Rank #1 (Strong Buy), AGCO Corporation and Avery Dennison carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Myers Industries has an expected earnings growth rate of 16% for the ongoing year. In the past year, the stock has surged 47%.
AGCO has an estimated earnings growth rate of 30% for 2021. The company’s shares have rallied 87% in the past year.
Avery Dennison has a projected earnings growth rate of 11% for the current year. Shares of the company have gained 35% over the past year.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
John Bean (JBT) Earnings and Revenues Surpass Estimates in Q4
John Bean Technologies Corporation (JBT - Free Report) reported adjusted earnings of $1.02 per share in fourth-quarter 2020, surpassing the Zacks Consensus Estimate of 89 cents by a margin of 15%. However, the bottom line declined 32% from the prior-year quarter reflecting the impact of the COVID-19 pandemic as reductions in global passenger air travel and global foodservice production impacted demand for the company’s products and services.
On a reported basis, the company’s earnings per share was 94 cents compared with the prior-year quarter’s $1.31.
Revenues of $439 million beat the Zacks Consensus Estimate of $428 million. Further, the top line slumped 20% from the prior-year quarter figure of $545 million.
John Bean Technologies Corporation Price, Consensus and EPS Surprise
John Bean Technologies Corporation price-consensus-eps-surprise-chart | John Bean Technologies Corporation Quote
In the reported quarter, the company’s total orders went up 2% to $492 million from the prior-year quarter. Orders in the JBT FoodTech segment dipped 2% year over year to $364 million. In the JBT AeroTech segment, orders improved 14% to $128 million from the prior-year quarter.
Backlog in the FoodTech segment increased 6% from the year-ago quarter to $427 million as of fourth-quarter 2020 end. The AeroTech segment’s backlog was $287 million at the end of the reported quarter, down 6% from the prior-year quarter. Total backlog of $713 million as of the end of the fourth quarter was up 1% year over year.
Cost and Margins
Cost of sales decreased 19% year over year to $306 million in the fourth quarter. Gross profit slumped 21% year over year to $133 million. Gross margin came in at 30.3% compared with the year-earlier quarter’s 30.8%.
Selling, general and administrative expenses were down 14% year over year to $89 million. Adjusted operating profit declined 32% year over year to $47 million. Adjusted operating margin was 10.7%, down 200 basis points from 12.7% in the prior-year quarter. In the reported quarter, adjusted EBITDA was around $660 million, reflecting a year-over-year plunge of 25%. Adjusted EBITDA margin was 15%, down from 16% in the year-ago quarter.
Segment Performance
JBT FoodTech: Net sales fell 10% year over year to $321 million as increase in recurring revenues was offset by decline in equipment demand. Adjusted operating profit amounted to $43.6 million, reflecting a decline of 18% from the prior-year quarter.
JBT AeroTech: Net sales were $118 million, reflecting a decline of 37% from the prior-year quarter. The segment’s adjusted operating profit plunged 56% year over year to $12.7 million.
Financial Performance
John Bean reported cash and cash equivalents of around $47.5 million at the end of 2020, up from $39.5 million at the end of fiscal 2019. The company generated around $252 million of cash from operating activities during 2020 compared with $111 million in the prior year. At the end of 2020, long-term debt was $522 million, down from $698 million as of end of 2019.
2020 Results
John Bean’s adjusted earnings per share in 2020 was $3.94, down 21% from the prior-year’s figure of $4.96. However, the bottom line beat the Zacks Consensus Estimate of $3.83. Including one-time items, the company delivered an earnings per share of $3.39 in 2020 compared with $4.03 in 2019. Sales declined 11% year over year to $1,729 million from the prior-year figure of $1,946 million. The top line surpassed the Zacks Consensus Estimate of $1,720 million.
Guidance
John Bean expects the seasonally slower first-quarter 2021 revenues to be $400-$425 million. While the FoodTech segments revenues for the ongoing quarter are projected between $300 million and $315 million, the same for the AeroTech segment are anticipated in the range of $100 million to $110 million.
The FoodTech segment’s operating margins are expected in the band of 13% to 13.5% and adjusted EBITDA margins to be 18.25-18.75%. For AeroTech, operating margins are forecasted to be 7.0-7.5%, while adjusted EBITDA margins are expected between 8.0% and 8.5%. Earnings per share for first-quarter 2021 is expected to range between 70 cents to 80 cents.
For 2021, John Bean anticipates an increase of 5-8% in revenues for the FoodTech segment. Operating margins are expected between 14% and 15%, and adjusted EBITDA margins in the band of 19.5% to 20%.
The AeroTech segment’s revenue growth is expected to be flat to 5% in 2021. Operating margins are anticipated between 10.75% and 11.25%, and adjusted EBITDA margins in the range of 12.0% to 12.5%.
The company projects adjusted earnings per share to be $4.30-$4.55 for 2021. The mid-point of the guidance range suggests growth of 12% from earnings of $3.94 per share in 2020.
Price Performance
John Bean’s shares have gained 25% in the past year compared with the industry’s rally of 73.9%.
Zacks Rank & Stocks to Consider
John Bean carries a Zacks Rank #4 (Sell).
Some better-ranked stocks in the Industrial Products sector include Myers Industries, Inc. (MYE - Free Report) , AGCO Corporation (AGCO - Free Report) and Avery Dennison Corporation (AVY - Free Report) . While Myers Industries sports a Zacks Rank #1 (Strong Buy), AGCO Corporation and Avery Dennison carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Myers Industries has an expected earnings growth rate of 16% for the ongoing year. In the past year, the stock has surged 47%.
AGCO has an estimated earnings growth rate of 30% for 2021. The company’s shares have rallied 87% in the past year.
Avery Dennison has a projected earnings growth rate of 11% for the current year. Shares of the company have gained 35% over the past year.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>